MoneyWorks4Me

Godavari Drugs - Quaterly Results

14 Aug 2024 Evaluate
The sales declined to Rs. 322.08 millions for the June 2024 quarter as compared to Rs. 354.19 millions during the corresponding quarter last year.Net Profit witnessed a 101.48% growth almost the double from Rs. 8.10 millions to Rs. 16.32  millions  of same quarter last year.Operating profit surged to 39.98 millions from the corresponding previous quarter of 27.01 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 322.08 354.19 -9.07 322.08 354.19 -9.07 1567.12 1596.25 -1.82
Other Income 7.65 4.52 69.25 7.65 4.52 69.25 6.18 6.55 -5.65
PBIDT 39.98 27.01 48.02 39.98 27.01 48.02 139.22 105.76 31.64
Interest 14.35 11.10 29.28 14.35 11.10 29.28 49.15 39.27 25.16
PBDT 25.63 15.91 61.09 25.63 15.91 61.09 89.17 68.79 29.63
Depreciation 5.50 4.74 16.03 5.50 4.74 16.03 19.95 19.44 2.62
PBT 20.13 11.17 80.21 20.13 11.17 80.21 69.22 49.35 40.26
TAX 3.81 3.07 24.10 3.81 3.07 24.10 13.73 11.49 19.50
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 16.32 8.10 101.48 16.32 8.10 101.48 55.49 37.86 46.57
Equity 75.30 75.30 0.00 75.30 75.30 0.00 75.31 75.31 0.00
PBIDTM(%) 12.41 7.63 62.78 12.41 7.63 62.78 8.88 6.63 34.08
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..